Form 8-K SELECTA BIOSCIENCES INC For: Mar 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Selecta Biosciences (SELB) Tops Q4 EPS by 10c
March 10, 2022 8:11 AM ESTSelecta Biosciences (NASDAQ: SELB) reported Q4 EPS of $0.03, $0.10 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $29.94 million versus the consensus estimate of $17.58 million.
For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.
... More